Following an HIV treatment interruption, most children recover immunologically
Analytical treatment interruptions: minimising the risks and maximising their scientific value
HIV-positive participant in vaccine study passes virus to sexual partner during treatment interruption
Atripla or efavirenz plus Truvada failed one in 16 people in first year
Viral load in semen rapidly rebounds to infectious levels during HIV treatment breaks
One in nine people may be able to control their viral load after stopping treatment, US study finds
VRC01 antibody can delay but not prevent viral rebound after interruption of early treatment
Researchers report case of bone marrow transplant patient off ART for 288 days without HIV rebound
VRC01 antibody delays but does not prevent HIV rebound after antiretroviral treatment interruption
